I. Pavord
University of OxfordPoster Author Of 8 e-Posters
A1112 - Eosinophil Counts as a Biomarker of Oral Corticosteroid Treatment Success for Patients with COPD
Presenter:
Date
05/19/2019
Room
Room C141/C143/C149 (Level 1), KBHCCD
Session Name
A24 - COPD: THERAPY, IMAGING, AND MOLECULAR MARKERS
A1305 - Self-Administration of Mepolizumab Liquid Using a Single-Use Prefilled Autoinjector
Presenter:
Date
05/19/2019
Room
Area E (Hall F, Level 2), KBHCCD
Session Name
A32 - ASTHMA: CLINICAL STUDIES II
A2667 - Dupilumab Reduces Severe Exacerbations and Improves Lung Function in Late-Onset, Uncontrolled, Moderate-to-Severe Asthma Patients Enrolled in the LIBERTY ASTHMA QUEST Study
Presenter:
Date
05/20/2019
Room
Room D222-D224 (Level 2), KBHCCD
Session Name
B21 - SEVERE ASTHMA: CLINICAL AND MECHANISTIC STUDIES
A2671 - Characterisation of Exacerbations of Severe Eosinophilic Asthma on Mepolizumab Compared to Placebo
Presenter:
Date
05/20/2019
Room
Room D222-D224 (Level 2), KBHCCD
Session Name
B21 - SEVERE ASTHMA: CLINICAL AND MECHANISTIC STUDIES
A5958 - Disease Severity of Patients with High Blood Eosinophil Counts Treated for COPD Exacerbation with or Without Oral Corticosteroids
Presenter:
Date
05/22/2019
Room
Room C141/C143/C149 (Level 1), KBHCCD
Session Name
D23 - COPD: DIAGNOSIS AND EPIDEMIOLOGY
A7086 - Dupilumab Improved Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma
Presenter:
Date
05/22/2019
Room
Room D222-D224 (Level 2), KBHCCD
Session Name
D101 - CLINICAL AND TRANSLATIONAL STUDIES IN ASTHMA AND COPD
A7477 - Pragmatic Randomized Controlled Trial of Budesonide/Formoterol Reliever Therapy in Adults with Mild Asthma
Poster Board Number
525
Presenter:
Date
05/22/2019
Room
Room D222-D224 (Level 2), KBHCCD
Session Name
D101 - CLINICAL AND TRANSLATIONAL STUDIES IN ASTHMA AND COPD